Induction therapy including antithymocyte globulin induces marked alterations in T lymphocyte subpopulations after liver transplantation: results of a long-term study

Authors:

Abstract
Various immunosuppressive regiments aim to reduce the incidence of acute rejection after liver transplantation. The efficacy of antithymocyte globulin (ATG) induction therapy and short‐term effects on the cellular response have been demonstrated in several studies. Nevertheless, information about long‐term effects of ATG therapy on cellular responses and frequency of complications is limited. Therefore, we analyzed the effect of ATG administration within a cyclosporine‐based induction therapy, including azathioprine and prednisolone, on lymphocyte subsets and activation markers. We divided 35 liver transplant recipients into two groups according to their initial postoperative immunosuppression: a triple group without (n= 15) and a quadruple group with ATG (n= 20). The minimum observation time (flow cytometry analysis, clinical follow‐up) was 2 years. Patients treated with ATG had persistently lower percentages of T cells for at least 2 years postoperatively (PP+ T cells within 2 years (P+ and HLA‐DR+ T cells was temporarily higher in patients with ATG treatment (P+/CD57+ double positive cells in the late postoperative phase (P<0.05). In contrast, no differences could be observed between the two groups for major parameters of clinical outcome (acute rejections, servere infections, patient survival). We conclude that ATG therapy induces long‐lasting alterations in T‐cell subset composition. However, no beneficial clinical effect could be confirmed after liver transplantation.

This publication has 35 references indexed in Scilit: